← Eichor
Condition: Osteosarcoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Osteosarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and S
Phase 1/Phase 2 · 7 location(s) · St. Jude Children's Research Hospital · NCT06239272Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumo
Phase 1/Phase 2 · 71 location(s) · Merck Sharp & Dohme LLC · NCT06395103A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors
Phase 1 · 4 location(s) · Hangzhou DAC Biotechnology Co., Ltd. · NCT06926283Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
Phase 1 · 1 location(s) · Tcelltech Inc. · NCT07052383Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT07215611Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Phase 1 · 36 location(s) · Inhibrx Biosciences, Inc · NCT03715933Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Phase 1 · 3 location(s) · BioEclipse Therapeutics · NCT04282044Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma
Phase 2 · 1 location(s) · Shanxi Province Cancer Hospital · NCT06637007Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adol
Phase 1/Phase 2 · 3 location(s) · David S Shulman, MD · NCT06709495ICONIC: Improving Outcomes Through Collaboration in OsteosarComa
Phase N/A · 22 location(s) · University College, London · NCT04132895Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
Phase N/A · 8 location(s) · Kantonsspital Winterthur KSW · NCT04300257Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
Phase 2 · 1 location(s) · Peking University People's Hospital · NCT06714383Pediatric PET/MR Image Registry
Phase N/A · 1 location(s) · Stanford University · NCT03458520Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
NA · 3 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06796543Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT07502885Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/
Phase 1 · 1 location(s) · Emory University · NCT05400603Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma
Phase 2 · 1 location(s) · Institut Claudius Regaud · NCT04515459Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method
Phase N/A · 1 location(s) · University Hospital, Clermont-Ferrand · NCT07141862Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
NA · 16 location(s) · Centre Leon Berard · NCT04055220Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
Phase 1 · 2 location(s) · Children's National Research Institute · NCT07172958START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Phase 1 · 7 location(s) · Valo Therapeutics Oy · NCT05492682A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
NA · 3 location(s) · Ricoh USA, Inc. · NCT06387485Single Arm Romiplostim to Prevent CIT
EARLY_Phase 1 · 2 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07048249DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma
Phase 1/Phase 2 · 1 location(s) · Montefiore Medical Center · NCT06892678Donor Site Morbidity After Free Vascularized Fibular Graft
Phase N/A · 1 location(s) · Assiut University · NCT06324916T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissu
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06474676Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplast
Phase 1/Phase 2 · 28 location(s) · National Cancer Institute (NCI) · NCT04616560Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Phase N/A · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT03160274
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.